ArticleClinical and translational gastroenterology2022

Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma.

Doron Yablecovitch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.